✦ LIBER ✦

Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: A multi-institutional case–control study

✍ Scribed by Matthias Zimmermann; Stefanie Nickl; Christopher Lambers; Stefan Hacker; Andreas Mitterbauer; Konrad Hoetzenecker; Anita Rozsas; Gyula Ostoros; Viktoria Laszlo; Helmut Hofbauer; Ferenc Renyi-Vamos; Walter Klepetko; Balazs Dome; Hendrik Jan Ankersmit

Book ID: 116349499
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 305 KB
Volume: 413
Category: Article
ISSN: 0009-8981
DOI: 10.1016/j.cca.2012.03.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Stereotactic hypofractionated high-dose

Stereotactic hypofractionated high-dose irradiation for patients with stage I non-small cell lung carcinoma: clinical outcomes in 241 cases of a Japanese multi-institutional study

✍ H Onishi; Y Nagata; H Shirato; K Gomi; K Karasawa; K Hayakawa; Y Takai; T Kimura 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 21 KB

E49. Stereotactic hypofractionated high-

E49. Stereotactic hypofractionated high-dose irradiation (STI) for stage I non-small cell lung cancer: Clinical outcomes in 298 cases of a Japanese multi-institutional study

✍ Onishi, Hiroshi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Quantitative modifications of TNM stagin

Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy — A retrospective study

✍ Abramyuk, Andrij; Appold, Steffen; Zöphel, Klaus; Hietschold, Volker; Baumann, M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Phase II multi-institutional study of Ir

Phase II multi-institutional study of Irinotecan (CPT-11) and Cisplatin (CDDP) on a three-week schedule in patients with advanced non-small cell lung cancer (NSCLC)

✍ Cardenal, F.; Domine, M.; Massuti, B.; Felip, E.; Carrato, A.; Garrido, P.; Albe 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 160 KB

PCN9 OBSERVATIONAL STUDY OF PATIENTS WIT

PCN9 OBSERVATIONAL STUDY OF PATIENTS WITH NON SMALL CELL LUNG CANCER (NSCLC) TREATED BY ERLOTINIB: CLINICAL PRACTICES AND MAIN OUTCOMES IN FRANCE

✍ A Vergnenegre; I Monnet; C Chouaid; J Hureaux; J Mazières; G Quéré; JN Lombard; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

The value of limited resection for ‘clin

The value of limited resection for ‘clinical’ stage I peripheral non-small cell lung cancer in poor-risk patients: Comparison of limited resection and lobectomy by a computer-assisted matched study

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 131 KB